Author

Ashley Sunderland

University of Leeds

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Alena Revalová· 1 shared Andrew S. MacDonaldiD· 1 shared Christopher M. FifeiD· 1 shared Dario Guglietta· 1 shared David R. WestheadiD· 1 shared Elton J. R. VasconcelosiD· 1 shared Fiona JamesiD· 1 shared Grace MallettiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alena Revalová

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Conventional dendritic cells type I with an enhanced type-I-IFN signaling underpin anti-tumor immune responses in brain metastases

Fiona James, Alena Revalová, Christopher M. Fife, Jennifer Williams, Dario Guglietta, Zarnaz Hadi, Elton J. R. Vasconcelos, Ashley Sunderland, Grace Mallett, Nicola Ingram, Tsuneyasu Kaisho, William J. Brackenbury, Merin Lawrence, David R. Westhead, Andrew S. MacDonald, Mihaela Lorger

This study identifies conventional dendritic cells type 1 (cDC1s) as critical for anti-tumor immunity in brain metastases, showing their unique role in promoting CD8+ T cell responses and enhancing immunotherapy efficacy.

bioRxiv · Jul 8, 2026 · PreprintCancer Biology